MiniMed Group, Inc.

MMED Healthcare Medical Instruments & Supplies

MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.

18.23 1.06 −5.50%
Market cap
$5.1B
P/E
0.0×
Fwd P/E
27.8×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−3.09
Dividend safety
n/a

MiniMed Group, Inc. (MMED) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, MiniMed Group, Inc. (MMED) trades at a P/B ratio of 1.4×. Over the past ten years it has ranged from 0.8× (May 2026) to 1.9× (September 2026); the current reading is higher than 64% of that period. That is below the Medical Instruments & Supplies industry median of 2.3× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2026 0.9× (36.00%)
FY2025 1.3× 0.00%
FY2024 1.3× —

Quarterly newest first

Period P/B ratio Change
Jul 2026 1.4× 3.80%
Jan 2026 1.3× 0.00%
Jul 2025 1.3× 0.00%
Jan 2025 1.3× —

Against its own ten years

Low 0.8× High 1.9×
Ten-year median 1.2×
Current reading's percentile 64

P/B ratio against peers

Company P/B ratio
BLCO Bausch + Lomb Corporation compare 1.1×
NVST Envista Holdings Corporation compare 1.3×
MMED MiniMed Group, Inc. 1.4×
ICUI ICU Medical, Inc. compare 1.9×
STVN Stevanato Group S.p.A. compare 2.0×
TFX Teleflex Incorporated compare 2.3×
MMSI Merit Medical Systems, Inc. compare 3.1×
ATRC AtriCure, Inc. compare 5.6×
PLSE Pulse Biosciences, Inc compare 20.8×
Medical Instruments & Supplies industry median 2.3×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on MMED